nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—prostate cancer	0.166	0.662	CbGaD
Acetylsalicylic acid—migraine—Prednisone—prostate cancer	0.134	0.508	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—prostate cancer	0.129	0.492	CpDpCtD
Acetylsalicylic acid—CYP2C19—prostate cancer	0.0521	0.208	CbGaD
Acetylsalicylic acid—PTGS2—prostate cancer	0.0324	0.13	CbGaD
Acetylsalicylic acid—ALB—Abiraterone—prostate cancer	0.0166	0.0637	CbGbCtD
Acetylsalicylic acid—CYP2C8—Nilutamide—prostate cancer	0.0155	0.0594	CbGbCtD
Acetylsalicylic acid—CYP2C19—Bicalutamide—prostate cancer	0.013	0.0499	CbGbCtD
Acetylsalicylic acid—CYP2C19—Nilutamide—prostate cancer	0.013	0.0499	CbGbCtD
Acetylsalicylic acid—CYP2C8—Abiraterone—prostate cancer	0.0129	0.0492	CbGbCtD
Acetylsalicylic acid—ALB—Estrone—prostate cancer	0.012	0.0461	CbGbCtD
Acetylsalicylic acid—SLC22A7—Docetaxel—prostate cancer	0.0114	0.0436	CbGbCtD
Acetylsalicylic acid—CYP2C9—Bicalutamide—prostate cancer	0.0108	0.0414	CbGbCtD
Acetylsalicylic acid—CYP2C9—Nilutamide—prostate cancer	0.0108	0.0414	CbGbCtD
Acetylsalicylic acid—CYP2C19—Flutamide—prostate cancer	0.0108	0.0413	CbGbCtD
Acetylsalicylic acid—ABCB1—Estramustine—prostate cancer	0.00976	0.0374	CbGbCtD
Acetylsalicylic acid—CYP2C8—Cabazitaxel—prostate cancer	0.00951	0.0364	CbGbCtD
Acetylsalicylic acid—SLC22A6—Conjugated Estrogens—prostate cancer	0.00924	0.0354	CbGbCtD
Acetylsalicylic acid—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00829	0.0317	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—prostate cancer	0.00715	0.0274	CbGbCtD
Acetylsalicylic acid—ALB—Estradiol—prostate cancer	0.00691	0.0265	CbGbCtD
Acetylsalicylic acid—CYP2C9—Estrone—prostate cancer	0.00648	0.0248	CbGbCtD
Acetylsalicylic acid—ABCB1—Cabazitaxel—prostate cancer	0.00644	0.0247	CbGbCtD
Acetylsalicylic acid—ABCB1—Estrone—prostate cancer	0.00629	0.0241	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—prostate cancer	0.00604	0.0231	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—prostate cancer	0.00594	0.0228	CbGbCtD
Acetylsalicylic acid—ABCB1—Ethinyl Estradiol—prostate cancer	0.00561	0.0215	CbGbCtD
Acetylsalicylic acid—CYP2C8—Estradiol—prostate cancer	0.00534	0.0204	CbGbCtD
Acetylsalicylic acid—CYP2C9—Capecitabine—prostate cancer	0.00491	0.0188	CbGbCtD
Acetylsalicylic acid—CYP2C19—Estradiol—prostate cancer	0.00448	0.0172	CbGbCtD
Acetylsalicylic acid—ABCB1—Conjugated Estrogens—prostate cancer	0.00412	0.0158	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—prostate cancer	0.00385	0.0147	CbGbCtD
Acetylsalicylic acid—ABCB1—Mitoxantrone—prostate cancer	0.00374	0.0143	CbGbCtD
Acetylsalicylic acid—CYP2C9—Estradiol—prostate cancer	0.00372	0.0143	CbGbCtD
Acetylsalicylic acid—ABCB1—Estradiol—prostate cancer	0.00361	0.0138	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—prostate cancer	0.00349	0.0133	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—prostate cancer	0.00311	0.0119	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—prostate cancer	0.00236	0.00904	CbGbCtD
Acetylsalicylic acid—ABCB1—Docetaxel—prostate cancer	0.00216	0.00827	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—prostate cancer	0.00161	0.00616	CbGbCtD
Acetylsalicylic acid—TP53—prostate gland—prostate cancer	0.0015	0.0373	CbGeAlD
Acetylsalicylic acid—NFKBIA—prostate gland—prostate cancer	0.00148	0.0367	CbGeAlD
Acetylsalicylic acid—HSPA5—prostate gland—prostate cancer	0.00145	0.036	CbGeAlD
Acetylsalicylic acid—NFKBIA—seminal vesicle—prostate cancer	0.00125	0.0311	CbGeAlD
Acetylsalicylic acid—RPS6KA3—prostate gland—prostate cancer	0.00123	0.0306	CbGeAlD
Acetylsalicylic acid—HSPA5—seminal vesicle—prostate cancer	0.00122	0.0304	CbGeAlD
Acetylsalicylic acid—CYP2C19—urine—prostate cancer	0.00119	0.0296	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—prostate cancer	0.0011	0.0274	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—prostate cancer	0.00109	0.027	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—prostate cancer	0.00106	0.0264	CbGeAlD
Acetylsalicylic acid—RPS6KA3—seminal vesicle—prostate cancer	0.00104	0.0259	CbGeAlD
Acetylsalicylic acid—TP53—renal system—prostate cancer	0.00102	0.0254	CbGeAlD
Acetylsalicylic acid—NFKBIA—renal system—prostate cancer	0.00101	0.025	CbGeAlD
Acetylsalicylic acid—TP53—urethra—prostate cancer	0.00101	0.025	CbGeAlD
Acetylsalicylic acid—EDNRA—prostate gland—prostate cancer	0.001	0.0249	CbGeAlD
Acetylsalicylic acid—NFKBIA—urethra—prostate cancer	0.000989	0.0246	CbGeAlD
Acetylsalicylic acid—HSPA5—renal system—prostate cancer	0.000986	0.0245	CbGeAlD
Acetylsalicylic acid—HSPA5—urethra—prostate cancer	0.000969	0.0241	CbGeAlD
Acetylsalicylic acid—CYP2C9—urine—prostate cancer	0.000923	0.023	CbGeAlD
Acetylsalicylic acid—IKBKB—prostate gland—prostate cancer	0.00091	0.0226	CbGeAlD
Acetylsalicylic acid—EDNRA—seminal vesicle—prostate cancer	0.000847	0.0211	CbGeAlD
Acetylsalicylic acid—RPS6KA3—renal system—prostate cancer	0.00084	0.0209	CbGeAlD
Acetylsalicylic acid—RPS6KA3—urethra—prostate cancer	0.000825	0.0205	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—prostate cancer	0.000774	0.0192	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—prostate cancer	0.000761	0.0189	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—prostate cancer	0.000746	0.0185	CbGeAlD
Acetylsalicylic acid—EDNRA—urethra—prostate cancer	0.000671	0.0167	CbGeAlD
Acetylsalicylic acid—TP53—testis—prostate cancer	0.000661	0.0164	CbGeAlD
Acetylsalicylic acid—NFKBIA—testis—prostate cancer	0.000651	0.0162	CbGeAlD
Acetylsalicylic acid—HSPA5—testis—prostate cancer	0.000637	0.0158	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—prostate cancer	0.000635	0.0158	CbGeAlD
Acetylsalicylic acid—IKBKB—urethra—prostate cancer	0.000609	0.0151	CbGeAlD
Acetylsalicylic acid—SLC22A7—renal system—prostate cancer	0.000601	0.0149	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—AKR1C3—prostate cancer	0.000572	0.373	CrCbGaD
Acetylsalicylic acid—RPS6KA3—testis—prostate cancer	0.000543	0.0135	CbGeAlD
Acetylsalicylic acid—NFKBIA—Paclitaxel—Cabazitaxel—prostate cancer	0.000495	0.196	CbGdCrCtD
Acetylsalicylic acid—TP53—lymph node—prostate cancer	0.000479	0.0119	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—prostate cancer	0.000472	0.0117	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—prostate cancer	0.000462	0.0115	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—AKR1C3—prostate cancer	0.000445	0.29	CrCbGaD
Acetylsalicylic acid—EDNRA—testis—prostate cancer	0.000441	0.011	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Abiraterone—prostate cancer	0.000436	0.172	CbGdCrCtD
Acetylsalicylic acid—IKBKB—testis—prostate cancer	0.000401	0.00996	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—prostate cancer	0.000393	0.00978	CbGeAlD
Acetylsalicylic acid—SLC22A7—testis—prostate cancer	0.000389	0.00966	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—prostate cancer	0.00032	0.00795	CbGeAlD
Acetylsalicylic acid—PTGS1—prostate gland—prostate cancer	0.000303	0.00752	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—prostate cancer	0.00029	0.00722	CbGeAlD
Acetylsalicylic acid—PTGS2—prostate gland—prostate cancer	0.000289	0.00719	CbGeAlD
Acetylsalicylic acid—PTGS1—seminal vesicle—prostate cancer	0.000256	0.00636	CbGeAlD
Acetylsalicylic acid—CYP2C8—renal system—prostate cancer	0.000254	0.00632	CbGeAlD
Acetylsalicylic acid—PTGS2—seminal vesicle—prostate cancer	0.000245	0.00608	CbGeAlD
Acetylsalicylic acid—ALB—testis—prostate cancer	0.000234	0.00581	CbGeAlD
Acetylsalicylic acid—PTGS1—epithelium—prostate cancer	0.000222	0.00553	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—prostate cancer	0.000213	0.00528	CbGeAlD
Acetylsalicylic acid—PTGS1—renal system—prostate cancer	0.000206	0.00513	CbGeAlD
Acetylsalicylic acid—NFKBIA—Paclitaxel—Docetaxel—prostate cancer	0.000206	0.0812	CbGdCrCtD
Acetylsalicylic acid—PTGS2—renal system—prostate cancer	0.000197	0.0049	CbGeAlD
Acetylsalicylic acid—PTGS2—urethra—prostate cancer	0.000194	0.00481	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Estramustine—prostate cancer	0.000181	0.0715	CbGdCrCtD
Acetylsalicylic acid—ABCB1—prostate gland—prostate cancer	0.000179	0.00445	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—prostate cancer	0.000175	0.114	CrCbGaD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—prostate cancer	0.000174	0.0688	CbGdCrCtD
Acetylsalicylic acid—ALB—lymph node—prostate cancer	0.00017	0.00421	CbGeAlD
Acetylsalicylic acid—CYP2C8—testis—prostate cancer	0.000164	0.00409	CbGeAlD
Acetylsalicylic acid—ABCB1—seminal vesicle—prostate cancer	0.000151	0.00376	CbGeAlD
Acetylsalicylic acid—PTGS2—bone marrow—prostate cancer	0.000149	0.00371	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Estrone—prostate cancer	0.000144	0.0568	CbGdCrCtD
Acetylsalicylic acid—PTGS1—testis—prostate cancer	0.000133	0.00331	CbGeAlD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—prostate cancer	0.000132	0.0522	CbGdCrCtD
Acetylsalicylic acid—ABCB1—epithelium—prostate cancer	0.000131	0.00327	CbGeAlD
Acetylsalicylic acid—ABCB1—renal system—prostate cancer	0.000122	0.00303	CbGeAlD
Acetylsalicylic acid—ABCB1—urethra—prostate cancer	0.00012	0.00298	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Estradiol—prostate cancer	0.000109	0.0431	CbGdCrCtD
Acetylsalicylic acid—Salsalate—PTGS2—prostate cancer	0.000102	0.0663	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—prostate cancer	0.0001	0.0654	CrCbGaD
Acetylsalicylic acid—PTGS1—lymph node—prostate cancer	9.66e-05	0.0024	CbGeAlD
Acetylsalicylic acid—PTGS2—lymph node—prostate cancer	9.24e-05	0.0023	CbGeAlD
Acetylsalicylic acid—ABCB1—bone marrow—prostate cancer	9.22e-05	0.00229	CbGeAlD
Acetylsalicylic acid—TP53—Danazol—Ethinyl Estradiol—prostate cancer	8.64e-05	0.0341	CbGdCrCtD
Acetylsalicylic acid—ABCB1—testis—prostate cancer	7.88e-05	0.00196	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS2—prostate cancer	7.8e-05	0.0508	CrCbGaD
Acetylsalicylic acid—TP53—Norethindrone—Ethinyl Estradiol—prostate cancer	7.78e-05	0.0308	CbGdCrCtD
Acetylsalicylic acid—Hypertension—Mitoxantrone—prostate cancer	7.3e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Shock—Estradiol—prostate cancer	7.29e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Estradiol—prostate cancer	7.23e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ethinyl Estradiol—prostate cancer	7.22e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mitoxantrone—prostate cancer	7.2e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mitoxantrone—prostate cancer	7.2e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Estradiol—prostate cancer	7.16e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Rash—Ethinyl Estradiol—prostate cancer	7.16e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ethinyl Estradiol—prostate cancer	7.15e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—prostate cancer	6.97e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Confusional state—Mitoxantrone—prostate cancer	6.96e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mitoxantrone—prostate cancer	6.9e-05	0.000992	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—prostate cancer	6.89e-05	0.0272	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—prostate cancer	6.89e-05	0.0272	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—prostate cancer	6.89e-05	0.0272	CbGdCrCtD
Acetylsalicylic acid—Hypersensitivity—Goserelin—prostate cancer	6.89e-05	0.00099	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Epirubicin—prostate cancer	6.88e-05	0.000989	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Conjugated Estrogens—prostate cancer	6.82e-05	0.000981	CcSEcCtD
Acetylsalicylic acid—Purpura—Epirubicin—prostate cancer	6.8e-05	0.000977	CcSEcCtD
Acetylsalicylic acid—Shock—Mitoxantrone—prostate cancer	6.79e-05	0.000976	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—prostate cancer	6.77e-05	0.000974	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mitoxantrone—prostate cancer	6.76e-05	0.000972	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Docetaxel—prostate cancer	6.75e-05	0.000971	CcSEcCtD
Acetylsalicylic acid—Nausea—Ethinyl Estradiol—prostate cancer	6.75e-05	0.00097	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mitoxantrone—prostate cancer	6.74e-05	0.000969	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Docetaxel—prostate cancer	6.72e-05	0.000966	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—prostate cancer	6.71e-05	0.000965	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mitoxantrone—prostate cancer	6.67e-05	0.000959	CcSEcCtD
Acetylsalicylic acid—Pruritus—Goserelin—prostate cancer	6.61e-05	0.000951	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Estradiol—prostate cancer	6.61e-05	0.00095	CcSEcCtD
Acetylsalicylic acid—Somnolence—Estradiol—prostate cancer	6.59e-05	0.000947	CcSEcCtD
Acetylsalicylic acid—Pruritus—Conjugated Estrogens—prostate cancer	6.55e-05	0.000942	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	6.55e-05	0.000942	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Capecitabine—prostate cancer	6.54e-05	0.00094	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Estradiol—prostate cancer	6.52e-05	0.000938	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Capecitabine—prostate cancer	6.5e-05	0.000935	CcSEcCtD
Acetylsalicylic acid—Anaemia—Etoposide—prostate cancer	6.5e-05	0.000935	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Goserelin—prostate cancer	6.4e-05	0.000919	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—prostate cancer	6.37e-05	0.0252	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—prostate cancer	6.37e-05	0.0252	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—prostate cancer	6.37e-05	0.0252	CbGdCrCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—prostate cancer	6.37e-05	0.000915	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Conjugated Estrogens—prostate cancer	6.33e-05	0.000911	CcSEcCtD
Acetylsalicylic acid—Vertigo—Etoposide—prostate cancer	6.32e-05	0.000909	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—prostate cancer	6.3e-05	0.000905	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—prostate cancer	6.29e-05	0.000904	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—prostate cancer	6.26e-05	0.0408	CrCbGaD
Acetylsalicylic acid—Flushing—Docetaxel—prostate cancer	6.23e-05	0.000896	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—prostate cancer	6.21e-05	0.000893	CcSEcCtD
Acetylsalicylic acid—TP53—Levonorgestrel—Ethinyl Estradiol—prostate cancer	6.19e-05	0.0245	CbGdCrCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—prostate cancer	6.18e-05	0.000889	CcSEcCtD
Acetylsalicylic acid—Dizziness—Goserelin—prostate cancer	6.18e-05	0.000888	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mitoxantrone—prostate cancer	6.16e-05	0.000885	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mitoxantrone—prostate cancer	6.14e-05	0.000882	CcSEcCtD
Acetylsalicylic acid—Dizziness—Conjugated Estrogens—prostate cancer	6.12e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Estradiol—prostate cancer	6.11e-05	0.000878	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—prostate cancer	6.1e-05	0.000876	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mitoxantrone—prostate cancer	6.08e-05	0.000874	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—prostate cancer	6.08e-05	0.000873	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Capecitabine—prostate cancer	6.06e-05	0.000872	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	6.06e-05	0.000871	CcSEcCtD
Acetylsalicylic acid—Flushing—Capecitabine—prostate cancer	6.04e-05	0.000868	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—prostate cancer	5.99e-05	0.000861	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—prostate cancer	5.96e-05	0.000857	CcSEcCtD
Acetylsalicylic acid—Vomiting—Goserelin—prostate cancer	5.94e-05	0.000854	CcSEcCtD
Acetylsalicylic acid—Rash—Goserelin—prostate cancer	5.89e-05	0.000847	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Goserelin—prostate cancer	5.89e-05	0.000846	CcSEcCtD
Acetylsalicylic acid—Vomiting—Conjugated Estrogens—prostate cancer	5.89e-05	0.000846	CcSEcCtD
Acetylsalicylic acid—Urticaria—Estradiol—prostate cancer	5.89e-05	0.000846	CcSEcCtD
Acetylsalicylic acid—Rash—Conjugated Estrogens—prostate cancer	5.84e-05	0.000839	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Conjugated Estrogens—prostate cancer	5.83e-05	0.000838	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—prostate cancer	5.82e-05	0.000837	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—prostate cancer	5.79e-05	0.000833	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etoposide—prostate cancer	5.79e-05	0.000832	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—prostate cancer	5.74e-05	0.000826	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—prostate cancer	5.71e-05	0.00142	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Mitoxantrone—prostate cancer	5.69e-05	0.000818	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—prostate cancer	5.66e-05	0.000814	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—prostate cancer	5.66e-05	0.000814	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—prostate cancer	5.62e-05	0.000808	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—prostate cancer	5.6e-05	0.000806	CcSEcCtD
Acetylsalicylic acid—Nausea—Goserelin—prostate cancer	5.55e-05	0.000798	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—prostate cancer	5.55e-05	0.000798	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—prostate cancer	5.52e-05	0.000793	CcSEcCtD
Acetylsalicylic acid—Nausea—Conjugated Estrogens—prostate cancer	5.5e-05	0.000791	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mitoxantrone—prostate cancer	5.48e-05	0.000788	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Estradiol—prostate cancer	5.46e-05	0.000785	CcSEcCtD
Acetylsalicylic acid—Anaemia—Docetaxel—prostate cancer	5.4e-05	0.000777	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—prostate cancer	5.38e-05	0.000773	CcSEcCtD
Acetylsalicylic acid—Syncope—Docetaxel—prostate cancer	5.24e-05	0.000754	CcSEcCtD
Acetylsalicylic acid—Pruritus—Estradiol—prostate cancer	5.24e-05	0.000754	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—prostate cancer	5.24e-05	0.000753	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—prostate cancer	5.24e-05	0.000753	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Docetaxel—prostate cancer	5.23e-05	0.000752	CcSEcCtD
Acetylsalicylic acid—Anaemia—Capecitabine—prostate cancer	5.23e-05	0.000752	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Docetaxel—prostate cancer	5.14e-05	0.000739	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—prostate cancer	5.12e-05	0.000736	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—prostate cancer	5.11e-05	0.000734	CcSEcCtD
Acetylsalicylic acid—Vertigo—Capecitabine—prostate cancer	5.09e-05	0.000731	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mitoxantrone—prostate cancer	5.09e-05	0.000731	CcSEcCtD
Acetylsalicylic acid—Syncope—Capecitabine—prostate cancer	5.08e-05	0.00073	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Estradiol—prostate cancer	5.07e-05	0.000729	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Capecitabine—prostate cancer	5.07e-05	0.000729	CcSEcCtD
Acetylsalicylic acid—Convulsion—Docetaxel—prostate cancer	5.07e-05	0.000728	CcSEcCtD
Acetylsalicylic acid—Hypertension—Docetaxel—prostate cancer	5.05e-05	0.000726	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—prostate cancer	5.05e-05	0.000726	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Docetaxel—prostate cancer	4.98e-05	0.000716	CcSEcCtD
Acetylsalicylic acid—Chest pain—Docetaxel—prostate cancer	4.98e-05	0.000716	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Capecitabine—prostate cancer	4.98e-05	0.000715	CcSEcCtD
Acetylsalicylic acid—Dizziness—Estradiol—prostate cancer	4.9e-05	0.000704	CcSEcCtD
Acetylsalicylic acid—Hypertension—Capecitabine—prostate cancer	4.89e-05	0.000703	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—prostate cancer	4.84e-05	0.000696	CcSEcCtD
Acetylsalicylic acid—Chest pain—Capecitabine—prostate cancer	4.82e-05	0.000693	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Capecitabine—prostate cancer	4.82e-05	0.000693	CcSEcCtD
Acetylsalicylic acid—Confusional state—Docetaxel—prostate cancer	4.81e-05	0.000692	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Docetaxel—prostate cancer	4.77e-05	0.000686	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—prostate cancer	4.73e-05	0.00068	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mitoxantrone—prostate cancer	4.72e-05	0.000679	CcSEcCtD
Acetylsalicylic acid—Vomiting—Estradiol—prostate cancer	4.71e-05	0.000677	CcSEcCtD
Acetylsalicylic acid—Shock—Docetaxel—prostate cancer	4.7e-05	0.000675	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Docetaxel—prostate cancer	4.67e-05	0.000672	CcSEcCtD
Acetylsalicylic acid—Rash—Estradiol—prostate cancer	4.67e-05	0.000672	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—prostate cancer	4.67e-05	0.000671	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Estradiol—prostate cancer	4.67e-05	0.000671	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—prostate cancer	4.66e-05	0.00067	CcSEcCtD
Acetylsalicylic acid—Confusional state—Capecitabine—prostate cancer	4.66e-05	0.00067	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Docetaxel—prostate cancer	4.66e-05	0.00067	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—prostate cancer	4.63e-05	0.000666	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—prostate cancer	4.61e-05	0.000662	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—prostate cancer	4.56e-05	0.000656	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—prostate cancer	4.55e-05	0.000655	CcSEcCtD
Acetylsalicylic acid—Shock—Capecitabine—prostate cancer	4.55e-05	0.000654	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—prostate cancer	4.53e-05	0.000651	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—prostate cancer	4.53e-05	0.000651	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Capecitabine—prostate cancer	4.52e-05	0.00065	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—prostate cancer	4.52e-05	0.00065	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Capecitabine—prostate cancer	4.51e-05	0.000648	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—prostate cancer	4.48e-05	0.000644	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Capecitabine—prostate cancer	4.47e-05	0.000642	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—prostate cancer	4.43e-05	0.000637	CcSEcCtD
Acetylsalicylic acid—Nausea—Estradiol—prostate cancer	4.4e-05	0.000633	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mitoxantrone—prostate cancer	4.39e-05	0.000631	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—prostate cancer	4.37e-05	0.000628	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—prostate cancer	4.35e-05	0.000626	CcSEcCtD
Acetylsalicylic acid—Rash—Mitoxantrone—prostate cancer	4.35e-05	0.000626	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mitoxantrone—prostate cancer	4.35e-05	0.000625	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—prostate cancer	4.29e-05	0.000617	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Docetaxel—prostate cancer	4.25e-05	0.000612	CcSEcCtD
Acetylsalicylic acid—Somnolence—Docetaxel—prostate cancer	4.24e-05	0.00061	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Etoposide—prostate cancer	4.23e-05	0.000608	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—prostate cancer	4.22e-05	0.000607	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—prostate cancer	4.21e-05	0.000606	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—prostate cancer	4.21e-05	0.000604	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Docetaxel—prostate cancer	4.2e-05	0.000604	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—prostate cancer	4.19e-05	0.000603	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Capecitabine—prostate cancer	4.12e-05	0.000592	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—prostate cancer	4.12e-05	0.000592	CcSEcCtD
Acetylsalicylic acid—Nausea—Mitoxantrone—prostate cancer	4.1e-05	0.00059	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Capecitabine—prostate cancer	4.07e-05	0.000585	CcSEcCtD
Acetylsalicylic acid—Pruritus—Etoposide—prostate cancer	4.06e-05	0.000584	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—prostate cancer	4.05e-05	0.000582	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—prostate cancer	4.02e-05	0.000577	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—prostate cancer	3.98e-05	0.000572	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Docetaxel—prostate cancer	3.93e-05	0.000565	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Etoposide—prostate cancer	3.93e-05	0.000565	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—prostate cancer	3.91e-05	0.000562	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—prostate cancer	3.89e-05	0.000559	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Capecitabine—prostate cancer	3.81e-05	0.000547	CcSEcCtD
Acetylsalicylic acid—Dizziness—Etoposide—prostate cancer	3.8e-05	0.000546	CcSEcCtD
Acetylsalicylic acid—Urticaria—Capecitabine—prostate cancer	3.67e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—prostate cancer	3.65e-05	0.000525	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—prostate cancer	3.65e-05	0.000524	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—prostate cancer	3.62e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—prostate cancer	3.62e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—prostate cancer	3.62e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—prostate cancer	3.62e-05	0.00052	CcSEcCtD
Acetylsalicylic acid—Vertigo—Epirubicin—prostate cancer	3.54e-05	0.000509	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—prostate cancer	3.54e-05	0.000508	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—prostate cancer	3.53e-05	0.000508	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Docetaxel—prostate cancer	3.52e-05	0.000505	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—prostate cancer	3.47e-05	0.000498	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—prostate cancer	3.42e-05	0.000491	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—prostate cancer	3.41e-05	0.00049	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—prostate cancer	3.41e-05	0.00049	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Capecitabine—prostate cancer	3.4e-05	0.000489	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—prostate cancer	3.39e-05	0.000488	CcSEcCtD
Acetylsalicylic acid—Pruritus—Docetaxel—prostate cancer	3.38e-05	0.000485	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—prostate cancer	3.37e-05	0.000485	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—prostate cancer	3.36e-05	0.000483	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—prostate cancer	3.36e-05	0.000483	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—prostate cancer	3.35e-05	0.000482	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—prostate cancer	3.28e-05	0.000471	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—prostate cancer	3.27e-05	0.00047	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—prostate cancer	3.27e-05	0.00047	CcSEcCtD
Acetylsalicylic acid—Pruritus—Capecitabine—prostate cancer	3.27e-05	0.00047	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—prostate cancer	3.27e-05	0.00047	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Docetaxel—prostate cancer	3.27e-05	0.000469	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—prostate cancer	3.25e-05	0.000467	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—prostate cancer	3.22e-05	0.000463	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—prostate cancer	3.21e-05	0.000461	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—prostate cancer	3.17e-05	0.000455	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—prostate cancer	3.16e-05	0.000455	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Capecitabine—prostate cancer	3.16e-05	0.000454	CcSEcCtD
Acetylsalicylic acid—Dizziness—Docetaxel—prostate cancer	3.16e-05	0.000454	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—prostate cancer	3.15e-05	0.000453	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—prostate cancer	3.15e-05	0.000453	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—prostate cancer	3.14e-05	0.000452	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—prostate cancer	3.11e-05	0.000447	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—prostate cancer	3.11e-05	0.000447	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—prostate cancer	3.11e-05	0.000447	CcSEcCtD
Acetylsalicylic acid—Dizziness—Capecitabine—prostate cancer	3.06e-05	0.000439	CcSEcCtD
Acetylsalicylic acid—Vomiting—Docetaxel—prostate cancer	3.03e-05	0.000436	CcSEcCtD
Acetylsalicylic acid—TP53—Danazol—Prednisone—prostate cancer	3.03e-05	0.012	CbGdCrCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—prostate cancer	3.03e-05	0.000436	CcSEcCtD
Acetylsalicylic acid—Rash—Docetaxel—prostate cancer	3.01e-05	0.000433	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Docetaxel—prostate cancer	3.01e-05	0.000432	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—prostate cancer	3e-05	0.000432	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—prostate cancer	2.98e-05	0.000428	CcSEcCtD
Acetylsalicylic acid—Vomiting—Capecitabine—prostate cancer	2.94e-05	0.000422	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—prostate cancer	2.93e-05	0.000421	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—prostate cancer	2.92e-05	0.000419	CcSEcCtD
Acetylsalicylic acid—Rash—Capecitabine—prostate cancer	2.91e-05	0.000419	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—prostate cancer	2.91e-05	0.000419	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Capecitabine—prostate cancer	2.91e-05	0.000418	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—prostate cancer	2.91e-05	0.000418	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—prostate cancer	2.88e-05	0.000414	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—prostate cancer	2.87e-05	0.000413	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—prostate cancer	2.86e-05	0.000411	CcSEcCtD
Acetylsalicylic acid—Nausea—Docetaxel—prostate cancer	2.83e-05	0.000408	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—prostate cancer	2.83e-05	0.000407	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—prostate cancer	2.82e-05	0.000405	CcSEcCtD
Acetylsalicylic acid—Nausea—Capecitabine—prostate cancer	2.74e-05	0.000395	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—prostate cancer	2.72e-05	0.000391	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—prostate cancer	2.66e-05	0.000382	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—prostate cancer	2.65e-05	0.000381	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—prostate cancer	2.65e-05	0.000381	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—prostate cancer	2.62e-05	0.000377	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—prostate cancer	2.62e-05	0.000376	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—prostate cancer	2.6e-05	0.000373	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—prostate cancer	2.59e-05	0.000373	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—prostate cancer	2.56e-05	0.000368	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—prostate cancer	2.45e-05	0.000353	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—prostate cancer	2.44e-05	0.000351	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—prostate cancer	2.37e-05	0.000341	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—prostate cancer	2.37e-05	0.00034	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—prostate cancer	2.28e-05	0.000327	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—prostate cancer	2.2e-05	0.000317	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—prostate cancer	2.19e-05	0.000315	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—prostate cancer	2.13e-05	0.000306	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—prostate cancer	2.11e-05	0.000303	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—prostate cancer	2.05e-05	0.000294	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—prostate cancer	2.04e-05	0.000293	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—prostate cancer	2.03e-05	0.000292	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—prostate cancer	2.03e-05	0.000291	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—prostate cancer	1.97e-05	0.000283	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—prostate cancer	1.91e-05	0.000275	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—prostate cancer	1.89e-05	0.000272	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—prostate cancer	1.88e-05	0.00027	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—prostate cancer	1.88e-05	0.00027	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—prostate cancer	1.77e-05	0.000254	CcSEcCtD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.23e-07	6.46e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—prostate cancer	7.22e-07	6.46e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—prostate cancer	7.22e-07	6.46e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—COMT—prostate cancer	7.2e-07	6.43e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1B1—prostate cancer	7.17e-07	6.41e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—prostate cancer	7.17e-07	6.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—prostate cancer	7.17e-07	6.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—prostate cancer	7.16e-07	6.4e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—INS—prostate cancer	7.16e-07	6.4e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—COMT—prostate cancer	7.16e-07	6.4e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—prostate cancer	7.15e-07	6.4e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—prostate cancer	7.15e-07	6.39e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CREBBP—prostate cancer	7.13e-07	6.37e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—prostate cancer	7.12e-07	6.37e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GGT1—prostate cancer	7.12e-07	6.36e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS1—prostate cancer	7.09e-07	6.34e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGF—prostate cancer	7.09e-07	6.34e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—prostate cancer	7.07e-07	6.32e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2E1—prostate cancer	7.07e-07	6.32e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ITPR1—prostate cancer	7.05e-07	6.3e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—prostate cancer	7.04e-07	6.3e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—prostate cancer	7.04e-07	6.29e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CREBBP—prostate cancer	7.02e-07	6.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARA—prostate cancer	7.02e-07	6.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NCOA1—prostate cancer	7.01e-07	6.27e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ITPR1—prostate cancer	7.01e-07	6.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NQO1—prostate cancer	6.99e-07	6.25e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—prostate cancer	6.99e-07	6.25e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—prostate cancer	6.99e-07	6.25e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GGT1—prostate cancer	6.95e-07	6.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.93e-07	6.2e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP19A1—prostate cancer	6.91e-07	6.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.89e-07	6.16e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TH—prostate cancer	6.89e-07	6.16e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—GSK3B—prostate cancer	6.88e-07	6.15e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.85e-07	6.12e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NCOA1—prostate cancer	6.84e-07	6.12e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP3A4—prostate cancer	6.82e-07	6.09e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAP2K1—prostate cancer	6.81e-07	6.08e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—INS—prostate cancer	6.79e-07	6.07e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.78e-07	6.06e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CD—prostate cancer	6.76e-07	6.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP19A1—prostate cancer	6.75e-07	6.03e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1B1—prostate cancer	6.7e-07	5.99e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SERPINE1—prostate cancer	6.69e-07	5.98e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RXRA—prostate cancer	6.67e-07	5.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TYMS—prostate cancer	6.66e-07	5.95e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CD—prostate cancer	6.65e-07	5.95e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CREBBP—prostate cancer	6.65e-07	5.95e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TYMS—prostate cancer	6.62e-07	5.92e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—prostate cancer	6.6e-07	5.9e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAV1—prostate cancer	6.6e-07	5.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—prostate cancer	6.58e-07	5.89e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—prostate cancer	6.58e-07	5.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—prostate cancer	6.55e-07	5.85e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—prostate cancer	6.52e-07	5.83e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RXRA—prostate cancer	6.51e-07	5.82e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GGT1—prostate cancer	6.49e-07	5.8e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.49e-07	5.8e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGF2—prostate cancer	6.47e-07	5.79e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—LPL—prostate cancer	6.46e-07	5.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—LPL—prostate cancer	6.43e-07	5.74e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—COMT—prostate cancer	6.42e-07	5.74e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—prostate cancer	6.4e-07	5.72e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—prostate cancer	6.4e-07	5.72e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—prostate cancer	6.4e-07	5.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—prostate cancer	6.39e-07	5.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NCOA1—prostate cancer	6.39e-07	5.72e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—prostate cancer	6.38e-07	5.71e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAP2K1—prostate cancer	6.35e-07	5.68e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CD—prostate cancer	6.31e-07	5.64e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP19A1—prostate cancer	6.3e-07	5.63e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.3e-07	5.63e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ITPR1—prostate cancer	6.29e-07	5.62e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—prostate cancer	6.28e-07	5.62e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—COMT—prostate cancer	6.27e-07	5.61e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—prostate cancer	6.24e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A1—prostate cancer	6.24e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SERPINE1—prostate cancer	6.24e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A1—prostate cancer	6.21e-07	5.55e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JAK2—prostate cancer	6.2e-07	5.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ERCC2—prostate cancer	6.19e-07	5.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.19e-07	5.53e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ERCC2—prostate cancer	6.15e-07	5.5e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ITPR1—prostate cancer	6.14e-07	5.49e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—prostate cancer	6.1e-07	5.45e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RXRA—prostate cancer	6.08e-07	5.44e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—prostate cancer	6.06e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—prostate cancer	6.05e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGF2—prostate cancer	6.04e-07	5.4e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—prostate cancer	6.01e-07	5.37e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—prostate cancer	5.97e-07	5.34e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—prostate cancer	5.96e-07	5.32e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TYMS—prostate cancer	5.94e-07	5.31e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.92e-07	5.29e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—prostate cancer	5.9e-07	5.27e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—prostate cancer	5.9e-07	5.27e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CB—prostate cancer	5.89e-07	5.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—prostate cancer	5.88e-07	5.25e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—COMT—prostate cancer	5.86e-07	5.24e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—prostate cancer	5.83e-07	5.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—prostate cancer	5.82e-07	5.2e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TYMS—prostate cancer	5.8e-07	5.19e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CB—prostate cancer	5.8e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—JAK2—prostate cancer	5.79e-07	5.17e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—prostate cancer	5.79e-07	5.17e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—LPL—prostate cancer	5.77e-07	5.16e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—prostate cancer	5.75e-07	5.14e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ITPR1—prostate cancer	5.74e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—prostate cancer	5.74e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARA—prostate cancer	5.71e-07	5.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—INS—prostate cancer	5.69e-07	5.08e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARA—prostate cancer	5.68e-07	5.07e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—prostate cancer	5.66e-07	5.06e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—prostate cancer	5.65e-07	5.05e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.64e-07	5.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—LPL—prostate cancer	5.63e-07	5.03e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—prostate cancer	5.6e-07	5.01e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A1—prostate cancer	5.57e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CREBBP—prostate cancer	5.57e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—prostate cancer	5.57e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—prostate cancer	5.56e-07	4.97e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—prostate cancer	5.53e-07	4.94e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ERCC2—prostate cancer	5.52e-07	4.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CB—prostate cancer	5.5e-07	4.91e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A1—prostate cancer	5.44e-07	4.86e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TYMS—prostate cancer	5.42e-07	4.85e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—prostate cancer	5.42e-07	4.84e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—prostate cancer	5.42e-07	4.84e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—prostate cancer	5.41e-07	4.84e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ERCC2—prostate cancer	5.39e-07	4.82e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAV1—prostate cancer	5.37e-07	4.8e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—prostate cancer	5.36e-07	4.79e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAV1—prostate cancer	5.34e-07	4.77e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CD—prostate cancer	5.28e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—prostate cancer	5.28e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—LPL—prostate cancer	5.26e-07	4.7e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—prostate cancer	5.22e-07	4.67e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—prostate cancer	5.19e-07	4.64e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—prostate cancer	5.16e-07	4.61e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.13e-07	4.58e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—prostate cancer	5.12e-07	4.58e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1A—prostate cancer	5.1e-07	4.56e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.1e-07	4.56e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARA—prostate cancer	5.09e-07	4.55e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—prostate cancer	5.09e-07	4.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A1—prostate cancer	5.08e-07	4.54e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—prostate cancer	5.07e-07	4.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ERCC2—prostate cancer	5.04e-07	4.5e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—prostate cancer	5.01e-07	4.48e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—prostate cancer	4.99e-07	4.46e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARA—prostate cancer	4.97e-07	4.45e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—prostate cancer	4.92e-07	4.4e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—prostate cancer	4.89e-07	4.37e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—prostate cancer	4.87e-07	4.36e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—prostate cancer	4.86e-07	4.35e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—prostate cancer	4.86e-07	4.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAV1—prostate cancer	4.79e-07	4.28e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—prostate cancer	4.78e-07	4.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1A—prostate cancer	4.76e-07	4.26e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—prostate cancer	4.75e-07	4.25e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—prostate cancer	4.74e-07	4.23e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—prostate cancer	4.72e-07	4.22e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAV1—prostate cancer	4.68e-07	4.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARA—prostate cancer	4.65e-07	4.15e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—INS—prostate cancer	4.63e-07	4.14e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CB—prostate cancer	4.6e-07	4.12e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—INS—prostate cancer	4.6e-07	4.11e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—prostate cancer	4.6e-07	4.11e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.58e-07	4.09e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—prostate cancer	4.57e-07	4.09e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—prostate cancer	4.55e-07	4.07e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—prostate cancer	4.54e-07	4.06e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CREBBP—prostate cancer	4.53e-07	4.05e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—prostate cancer	4.53e-07	4.05e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CREBBP—prostate cancer	4.51e-07	4.03e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—prostate cancer	4.4e-07	3.94e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAV1—prostate cancer	4.37e-07	3.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—prostate cancer	4.36e-07	3.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CD—prostate cancer	4.3e-07	3.84e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CD—prostate cancer	4.27e-07	3.82e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—prostate cancer	4.26e-07	3.81e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—prostate cancer	4.25e-07	3.8e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—prostate cancer	4.23e-07	3.78e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—prostate cancer	4.22e-07	3.77e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.17e-07	3.73e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—prostate cancer	4.14e-07	3.7e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—INS—prostate cancer	4.13e-07	3.69e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—prostate cancer	4.06e-07	3.63e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CREBBP—prostate cancer	4.05e-07	3.62e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—prostate cancer	4.03e-07	3.61e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—INS—prostate cancer	4.03e-07	3.6e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.98e-07	3.56e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—prostate cancer	3.98e-07	3.56e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CREBBP—prostate cancer	3.95e-07	3.53e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—prostate cancer	3.95e-07	3.53e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—prostate cancer	3.94e-07	3.52e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—prostate cancer	3.91e-07	3.5e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—prostate cancer	3.86e-07	3.45e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CD—prostate cancer	3.84e-07	3.43e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—prostate cancer	3.79e-07	3.39e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—INS—prostate cancer	3.77e-07	3.37e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CB—prostate cancer	3.75e-07	3.35e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CD—prostate cancer	3.74e-07	3.35e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CB—prostate cancer	3.72e-07	3.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—prostate cancer	3.71e-07	3.32e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—prostate cancer	3.69e-07	3.3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CREBBP—prostate cancer	3.69e-07	3.3e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—prostate cancer	3.65e-07	3.26e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—prostate cancer	3.62e-07	3.24e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—prostate cancer	3.59e-07	3.21e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—prostate cancer	3.54e-07	3.16e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—prostate cancer	3.54e-07	3.16e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CD—prostate cancer	3.5e-07	3.13e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—prostate cancer	3.47e-07	3.11e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—prostate cancer	3.35e-07	3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CB—prostate cancer	3.34e-07	2.99e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—prostate cancer	3.31e-07	2.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—prostate cancer	3.3e-07	2.95e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CB—prostate cancer	3.26e-07	2.92e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—prostate cancer	3.24e-07	2.89e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—prostate cancer	3.23e-07	2.89e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—prostate cancer	3.22e-07	2.88e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—prostate cancer	3.18e-07	2.84e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—prostate cancer	3.09e-07	2.76e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—prostate cancer	3.07e-07	2.74e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.05e-07	2.73e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—prostate cancer	3.02e-07	2.7e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—prostate cancer	2.97e-07	2.65e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—prostate cancer	2.93e-07	2.62e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—prostate cancer	2.89e-07	2.58e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—prostate cancer	2.89e-07	2.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—prostate cancer	2.82e-07	2.52e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—prostate cancer	2.81e-07	2.51e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—prostate cancer	2.76e-07	2.46e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—prostate cancer	2.74e-07	2.45e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—prostate cancer	2.69e-07	2.4e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—prostate cancer	2.63e-07	2.35e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—prostate cancer	2.51e-07	2.25e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—prostate cancer	2.29e-07	2.05e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.28e-07	2.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—prostate cancer	2.27e-07	2.03e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.04e-07	1.82e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—prostate cancer	1.99e-07	1.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—prostate cancer	1.87e-07	1.67e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.86e-07	1.66e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—prostate cancer	1.85e-07	1.66e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—prostate cancer	1.66e-07	1.49e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—prostate cancer	1.63e-07	1.45e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—prostate cancer	1.52e-07	1.36e-06	CbGpPWpGaD
